Diarrhea Parasite Statistics in US 2026 | Symptoms, Treatments & Key Facts

Diarrhea Parasites in the United States 2026

Diarrhea parasite statistics in US are dominated by an active, still-unfolding outbreak of cyclosporiasis, the so-called “explosive diarrhea” parasite, currently spreading across multiple states. As of 16 June 2026, the CDC had confirmed 190 total cases, including 145 domestically acquired infections across 17 states, while Michigan alone reported over 170 additional cases in just nine days starting 22 June 2026 — a figure the Michigan Department of Health and Human Services says is more than triple the state’s typical annual total of 50 cases.

This article compiles verified diarrhea parasite statistics in US 2026 from the CDC, NIH StatPearls, state health departments, and peer-reviewed surveillance research. It covers the three parasites responsible for the vast majority of parasitic diarrhea in America — Cyclospora, Cryptosporidium, and Giardia — along with their symptoms, treatment options, seasonal patterns, and the specific populations most at risk, giving a complete, data-backed picture of this year’s parasitic illness landscape.

Interesting Facts About Diarrhea Parasites in US 2026

Source: CDC; Michigan Department of Health and Human Services, 2026

As a diarrhea parasite statistics in US 2026 starting point, these numbers reveal both an active acute outbreak and a much larger, chronically underreported baseline problem. The current cyclosporiasis outbreak’s 190 confirmed cases may sound modest, but the Michigan spike alone — 170+ cases in nine days — shows how quickly a single regional cluster can outpace an entire state’s normal yearly total. Even more striking is the scale hiding beneath the headlines: cryptosporidiosis causes an estimated 748,000 US cases annually, yet fewer than 2% are ever formally reported to health authorities.

This underreporting gap matters because it shapes how outbreaks are detected and managed. With roughly half of all Giardia infections producing no symptoms at all, and both Cryptosporidium and Cyclospora requiring specific laboratory testing that isn’t always ordered during a routine doctor’s visit, the true national burden of parasitic diarrhea likely runs many multiples higher than what appears in official CDC surveillance figures, even during a high-visibility outbreak like the one unfolding right now.

Cyclosporiasis Outbreak Statistics in US 2026

Source: CDC Cyclosporiasis Surveillance, 2026

Cyclosporiasis, caused by the microscopic parasite Cyclospora cayetanensis, has produced 190 confirmed cases nationally as of mid-June 2026, split between 145 domestically acquired infections and 45 cases linked to international travel in the two weeks before illness onset. The CDC’s demographic breakdown shows cases spanning a wide age range, from just 5 years old to 86, with a median age of 42 and a notable female majority at 61% of domestic cases — a pattern consistent with prior cyclosporiasis seasons.

New York has reported the highest number of cases nationally, followed closely by Illinois and Texas, though the outbreak’s true geographic reach extends across states including Alaska, Colorado, Connecticut, Florida, Georgia, Louisiana, Massachusetts, New Jersey, North Carolina, Ohio, Pennsylvania, Tennessee, Virginia, and Wisconsin. As of mid-June, at least 20 people had been hospitalized, though no deaths have been reported, and health officials at both the CDC and FDA confirm they have not yet identified a confirmed contaminated food source behind the current cluster.

Michigan’s 2026 Cyclosporiasis Spike Statistics

Source: Michigan Department of Health and Human Services; CDC, 2026

Southeast Michigan has become the epicenter of the 2026 cyclosporiasis outbreak, with case counts climbing from 150 to over 170 in just a matter of days, spread across seven counties including Wayne, Washtenaw, and Monroe. Local health departments describe this as a “large and growing outbreak” requiring active investigation, especially notable given that Michigan typically identifies only about 50 cases in an entire year — meaning this single regional cluster has already tripled the state’s normal annual total within roughly a nine-day window.

Cyclosporiasis is a nationally notifiable disease, reportable in 47 states, the District of Columbia, and New York City, which allows the CDC to compile a relatively complete national picture compared with less-tracked parasitic illnesses. The disease follows a well-established seasonal pattern, running from 1 May through 31 August in most years, though officials note that clusters have occasionally appeared outside this window, and the true scope of Michigan’s outbreak may still be understated since case reporting always lags slightly behind actual infection dates.

Cryptosporidiosis Statistics in US 2026

Source: CDC MMWR Cryptosporidiosis Surveillance; NIH StatPearls, 2026

Cryptosporidiosis represents by far the largest hidden burden among US diarrhea parasites, with an estimated 748,000 cases occurring annually, yet historically fewer than 2% are ever captured in official surveillance data. The disease was the leading cause of all waterborne disease outbreaks in the United States between 2001 and 2010, and continues to generate an estimated $45.8 million in hospitalization costs every year, driven largely by the parasite’s chlorine-resistant oocysts, which allow it to survive standard pool and water treatment disinfection far longer than most other pathogens.

Beyond domestic transmission, Cryptosporidium is also a recognized cause of traveler’s diarrhea, accounting for 2% to 11% of protozoal infections among returning international travelers, with especially high rates linked to trips through South-Central Asia and sub-Saharan Africa. Notably, over 14% of travelers who contract cryptosporidiosis abroad require hospitalization upon return, a rate considerably higher than for many other traveler’s diarrhea causes, underscoring why the illness remains a persistent concern for immunocompromised individuals and young children in particular.

Giardiasis Statistics in US 2026

Source: CDC MMWR Giardiasis Outbreaks Report, 2012-2017 (most recent published dataset)

Giardiasis, caused by the parasite Giardia duodenalis, remains the most common cause of intestinal parasite infection in the United States, though roughly half of all infections produce no symptoms whatsoever, allowing the parasite to spread undetected through households and communities. A CDC-published analysis covering 2012 through 2017 identified 111 distinct giardiasis outbreaks across 26 states, totaling 760 primary cases, 28 hospitalizations, and 48 emergency department visits — figures that likely understate the true outbreak burden given how often giardiasis goes undiagnosed due to its frequently mild or absent symptoms.

The same CDC study found waterborne exposure responsible for 26% of outbreaks and person-to-person contact for another 25%, with contaminated food linked to just 5% of cases and the remaining 43% unable to be traced to a single confirmed transmission mode. Private residences and child care facilities emerged as the most common outbreak settings across nearly every transmission category, reflecting how easily the parasite spreads in close-contact environments where hand hygiene and surface disinfection may be inconsistent, particularly among young children who are especially prone to both infection and further transmission.

Symptoms Statistics for US Diarrhea Parasites in 2026

Source: CDC Cyclosporiasis, Cryptosporidium, and Giardia clinical fact sheets, 2026

All three parasites share a core symptom of watery diarrhea, but each carries distinct features clinicians use to help narrow a diagnosis. Cyclosporiasis is particularly known for producing frequent, sometimes explosive bowel movements, a symptom pattern that gives the illness its viral nickname, alongside cramping, nausea, and fatigue that can persist far longer than typical stomach bugs — without treatment, symptoms can last from a few days to a month or longer, and diarrhea may temporarily resolve before returning again.

Cryptosporidiosis similarly produces profuse, nonbloody, watery diarrhea, often accompanied by weight loss, abdominal cramps, and low-grade fever, generally resolving within 2 to 3 weeks in people with healthy immune systems, though recurrence after apparent recovery is common enough that clinicians frequently warn patients about it. Giardiasis stands apart somewhat with its characteristic greasy, foul-smelling stools alongside bloating and gas, and while most cases are self-limited, a subset of patients develop longer-term complications even after the parasite itself has been cleared from the body.

Treatment Statistics for US Diarrhea Parasites in 2026

Source: CDC Clinical Care Guidance; Medscape; peer-reviewed drug efficacy studies, 2026

Treatment approaches differ meaningfully across the three parasites, which is why accurate diagnosis matters as much as symptom management. Cryptosporidiosis treatment centers on nitazoxanide, the only FDA-approved drug specifically for the condition since 2005, delivering clinical cure rates of 72% to 88% and parasitologic cure rates of 60% to 75% in patients with healthy immune systems — though the drug has not been shown superior to placebo in HIV-infected or otherwise immunocompromised patients, leaving a significant treatment gap for the most vulnerable populations.

For giardiasis, metronidazole remains the most commonly prescribed antibiotic, typically dosed at 250mg three times daily for 5 to 7 days, while tinidazole offers a single-dose alternative with reported efficacy near 90% and generally fewer side effects. Cyclosporiasis, by contrast, responds well to trimethoprim-sulfamethoxazole, though people with sulfa allergies require alternative approaches, and in all three cases, adequate fluid intake to prevent dehydration remains a universally recommended supportive measure, particularly critical for young children, pregnant women, and older adults.

Seasonal Patterns and High-Risk Groups in US 2026

Source: CDC; UpToDate Giardiasis Epidemiology, 2026

All three major US diarrhea parasites follow recognizable seasonal patterns, generally peaking during the warmer spring and summer months when recreational water use, outdoor gatherings, and produce consumption all rise simultaneously. Cryptosporidium’s chlorine-resistant oocysts make swimming pools and water parks a particularly common transmission point during peak season, since the parasite can survive routine chlorine levels that would kill most other waterborne pathogens within minutes.

Children under 10 face measurably higher giardiasis rates than older individuals, a pattern researchers attribute to both immature hygiene habits and closer contact in child care settings, while severe cryptosporidiosis disproportionately affects malnourished children and immunocompromised adults, for whom the illness can become chronic rather than self-limiting. Given these overlapping seasonal and demographic risk factors, public health officials consistently emphasize that hand hygiene, avoiding swallowing recreational water, and thoroughly washing fresh produce remain the most effective, broadly applicable prevention strategies across all three parasites.

Global Burden and Historical Trend Statistics in US 2026

Source: UpToDate; CDC MMWR Cryptosporidiosis Surveillance 1995-2012; PMC epidemiological studies, 2026

Placed in global context, US diarrhea parasite statistics reflect a much smaller slice of a far larger worldwide problem. Giardia alone causes over 300 million annual cases among children under five globally, ranking as the third most common cause of childhood diarrheal disease after rotavirus and Cryptosporidium, with prevalence reaching 20% to 40% in regions with poor sanitation infrastructure — figures that dwarf the comparatively well-controlled US domestic burden, even accounting for America’s significant underreporting problem.

Historical US surveillance trends also help explain why current case counts look the way they do. CDC researchers note that reported cryptosporidiosis rates rose noticeably after 2004, a shift they link directly to the FDA’s 2005 approval of nitazoxanide, which likely increased healthcare provider awareness and prompted more diagnostic testing rather than reflecting a true rise in infections alone. The largest single historical spike came in 2007, when a statewide recreational water-associated outbreak in Utah pushed national case counts to their highest recorded level, a pattern of large, water-linked outbreaks that continues to define how cryptosporidiosis spreads across the United States to this day.

Diagnosis and Public Health Reporting Statistics in US 2026

Source: CDC; National Outbreak Reporting System (NORS), 2026

Accurate diagnosis and reporting infrastructure underpin every statistic in this article, and 2026 has brought notable improvements alongside persistent gaps. Cyclosporiasis benefits from unusually broad reportable-disease coverage, spanning 47 states, the District of Columbia, and New York City, which is precisely why the CDC was able to detect and respond to this year’s multi-state outbreak as quickly as it did through the National Outbreak Reporting System (NORS). CDC and FDA investigators continue working to identify a specific contaminated food source, though as of the most recent update, no single culprit has been confirmed despite the outbreak spanning 17 states.

Looking forward, CDC laboratories are actively rolling out whole-genome sequencing capabilities specifically for Cryptosporidium specimens, a technical advance expected to make it far easier to link scattered cases into confirmed outbreak clusters, similar to techniques already used for foodborne bacterial illnesses. For patients experiencing diarrhea lasting more than a few days, especially after travel, recreational water exposure, or contact with young children in group care settings, health officials recommend explicitly requesting parasitic stool testing rather than assuming a standard bacterial or viral panel will catch every possible cause, since routine testing does not always screen for Cyclospora, Cryptosporidium, or Giardia by default.

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE